NVDA
NVIDIA
-- 135.070 TSLA
Tesla
-- 400.990 AMD
Advanced Micro Devices
-- 127.740 GOOG
Alphabet-C
-- 186.530 PLTR
Palantir
-- 70.890 
Vaxart oral flu vaccine offers greater protection in human challenge study
$Vaxart (VXRT.US)$ Interesting... but how much improvement would be important to know. However showing results better than the injections is promising.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Brandon Golden : One must ask, if they were equally effective, what percent of people would select the needle vs a pill? Is the case more compelling for the product and stock when you answer that question?
Geminiasianboi Brandon Golden : Given the portability of the pill, its overall lower cost, with no requirement of having a professional administer an injection, 3rd party payers (insurance companies and Medicare) would likely step in immediately to reimburse the lower cost pill. They would save hundreds of millions annually. Because of this, patients would not be the choosers. If the pill is efficacious, it is the ultimate winner. VXRT could sell billions of flu pills annually across the globe.
IT farmer Geminiasianboi : Excellent points and perspective.
FuSioNx : hmm say if u are ill u will take pills..but if u need to travel or part of immunization prog, vaccination is still the way to go. 2 different approaches and business models
四月天666 : It's enough to watch the VXRT fool around